GATA6、ROR2和STAT3在膀胱移行细胞癌的表达及其意义

张龙波; 苟欣; 何卫阳; 周青松

doi:10.13406/j.cnki.cyxb.2011.05.022

您当前的位置：

首页 >

文章列表页 >

GATA6、ROR2和STAT3在膀胱移行细胞癌的表达及其意义

恶性肿瘤的诊断与治疗 | 更新时间：2024-01-17

- GATA6、ROR2和STAT3在膀胱移行细胞癌的表达及其意义
- Expression and significance of GATA6,ROR2 and STAT3 in bladder cell carcinoma
- 重庆医科大学学报 2011年36卷第5期页码：535-538
- 作者机构：
  
  重庆医科大学第一附属医院泌尿外科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2011.05.022
  中图分类号： R737.14
- 纸质出版日期：2011，
扫描看全文
[1]张龙波,苟欣,何卫阳,周青松.GATA6、ROR2和STAT3在膀胱移行细胞癌的表达及其意义[J].重庆医科大学学报,2011,36(05):535-538.

ZHANG Long-bo, GOU Xin, HE Wei-yang, et al. Expression and significance of GATA6,ROR2 and STAT3 in bladder cell carcinoma[J]. Journal of Chongqing Medical University, 2011,36(5):535-538.
[1]张龙波,苟欣,何卫阳,周青松.GATA6、ROR2和STAT3在膀胱移行细胞癌的表达及其意义[J].重庆医科大学学报,2011,36(05):535-538. DOI： 10.13406/j.cnki.cyxb.2011.05.022.

ZHANG Long-bo, GOU Xin, HE Wei-yang, et al. Expression and significance of GATA6,ROR2 and STAT3 in bladder cell carcinoma[J]. Journal of Chongqing Medical University, 2011,36(5):535-538. DOI： 10.13406/j.cnki.cyxb.2011.05.022.

摘要

目的:探讨核转录因子GATA6、发育调节激酶ROR2和信号转导因子STAT3在膀胱移行细胞癌中的表达及其临床意义。方法:采用免疫组织化学SP法检测72例膀胱移行细胞癌（Bladder transitional cell carcinoma

BTCC）组织中GATA6、ROR2和STAT3的表达

并将结果与病理分级、临床分期、肿瘤复发等临床病理资料进行统计学分析。结果:GATA6、ROR2和STAT3在BTCC的表达分别为:22.2%、61.1%、79.2%。不同病理分级和临床分期组间GATA6的表达差异无统计学意义（P>0.05）

但复发组与未复发组间其表达差异有统计学意义（P<0.05）;不同病理分级、临床分期

复发组与未复发组间ROR2的表达差异有统计学意义（P<0.05）;不同病理分级组间STAT3表达差异有统计学意义（P<0.05）

不同临床分期、复发与未复发组间差异无统计学意义（P>0.05）。（2）ROR2、STAT3在BTCC中的表达具有统计学相关性（rs=0.443

P<0.05）;GATA6在BTCC中的表达与ROR2、STAT3无统计学相关。结论:STAT3、ROR2和GATA6可能都参与了BTCC的进展;ROR2与STAT3可能存在共同的信号通路;检测GATA6、ROR2和STAT3可能对判断BTCC的进展和预后有一定价值。

Abstract

Objective:To investigate the expression and clinical significance of GATA6

ROR2

and STAT3 in bladder transitional cell carcinoma(BTCC).Methods:Expression of GATA6

ROR2

and STAT3 in 72 cases of BTCC detected by immunohistochemical SP method

and the results were analyzed statistically.Results:(1)The positive expression rate of GATA6 was significantly higher in recurrence group than in unrecurrence group(P<0.05)

while the expression of GATA6 did not increase with the ascended differentiation grade and pathology staging(P>0.05).(2)Positive expression rate of ROR2 in BTCC increased with the increase of differentiation grade and pathology staging(P<0.05)

and the expression rate of ROR2 was higher in recurrence group.(3)Positive rate of STAT3 in BTCC was significantly different among the different differentiation grade group(P<0.05)

and was of no significant difference in pathology staging group and recurrences group(P>0.05).(4)There was a highly significant positive correlation between the expression of ROR2 and STAT3(rs= 0.443

P<0.05)

but there was no significant positive correlation between ROR2 and GATA6

or between STAT3 and GATA6(P>0.05).Conclusion:GATA6

ROR2 and STAT3 might contribute to the development and recurrence of bladder transitional cell carcinoma.

关键词

膀胱移行细胞癌GATA6ROR2STAT3

Keywords

bladder transitional cell carcinomaGATA6ROR2STAT3

references

浏览量

167

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

新基因hepaCAM对膀胱癌细胞体外生物学影响

分化抑制因子3在胚胎植入中的作用

慢病毒介导STAT3-shRNA对胃癌细胞化疗敏感性的影响及机制